Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

42.50p
   
  • Change Today:
    -1.00p
  • 52 Week High: 160.00
  • 52 Week Low: 42.00
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 1
  • Market Cap: £16.05m

Regulatory News

Collaboration with global pharmaceutical partner 26-Mar-2025 07:00 RNS
Arecor partnership with biopharmaceutical company 12-Mar-2025 07:00 RNS
Arecor Full Year 2024 Trading Update 03-Feb-2025 07:00 RNS
Orderly Cessation of Tetris Pharma Operations 10-Jan-2025 07:45 RNS
Change of Nominated Advisor and Joint Broker 09-Jan-2025 07:00 RNS
Arecor Signs Exclusive Licensing Agreement 30-Dec-2024 07:00 RNS
Grant of Options and PDMR Dealing 02-Dec-2024 07:00 RNS
Arecor Appoints Interim Chief Financial Officer 18-Nov-2024 07:00 RNS
Interim Results for six months ended 30 June 2024 26-Sep-2024 07:00 RNS
Notice of Results 19-Sep-2024 15:17 RNS
Arecor presents positive AT278 data at EASD 11-Sep-2024 07:00 RNS
Holding(s) in Company 22-Aug-2024 16:34 RNS
Holding(s) in Company 20-Aug-2024 13:44 RNS
Holding(s) in Company 12-Aug-2024 15:02 RNS
Result of General Meeting and Total Voting Rights 08-Aug-2024 14:48 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AREC Market Data

Currency UK Pounds
Share Price 42.50p
Change Today -1.00p
% Change -2.30 %
52 Week High 160.00
52 Week Low 42.00
Volume 1
Shares Issued 37.76m
Market Cap £16.05m

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.83% below the market average36.83% below the market average36.83% below the market average36.83% below the market average36.83% below the market average
45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average
Price Trend
88.59% below the market average88.59% below the market average88.59% below the market average88.59% below the market average88.59% below the market average
67.35% below the sector average67.35% below the sector average67.35% below the sector average67.35% below the sector average67.35% below the sector average
Income Not Available
Growth
58.39% above the market average58.39% above the market average58.39% above the market average58.39% above the market average58.39% above the market average
61.29% above the sector average61.29% above the sector average61.29% above the sector average61.29% above the sector average61.29% above the sector average

AREC Dividends

No dividends found

Trades for 01-Apr-2025

Time Volume / Share Price
08:32 1 @ 42.00p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO David Ellam

Top of Page